NEW YORK(GenomeWeb) – Protein reagent firm Anatrace has completed its acquisition of Microlytic, which specializes in tools for the structural biology market.

In particular, Microlytic offers products intended to accelerate workflows and improve output quality in soluble protein crystallization.

Anatrace specializes in development and production of high-purity detergents and synthetic lipids for use in membrane protein work. The company is owned by StoneCalibre, a Century City, Calif.-based investment fund.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Sponsored by

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.